13F HOLDINGS REPORT
FCPM III SERVICES B.V.
Quarter ended Q1 2024 · Filed March 7, 2024 · Accession 0001802806-24-000019
Total Value
$339.4M
Positions
9
Other Managers
2
Confidential Omitted
No
Holdings (9)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | DYNE THERAPEUTICS INC | DYN | 6,131,079 | $81.5M | 24.03% |
| 2 | NEWAMSTERDAM PHARMA COMPANY | NAMSW | 6,635,391 | $74.1M | 21.84% |
| 3 | NEWAMSTERDAM PHARMA COMPANY | NAMSW | 5,196,070 | $58.0M | 17.10% |
| 4 | ENGENE HOLDINGS INC | ENGNW | 5,783,752 | $53.4M | 15.73% |
| 5 | REPLIMUNE GROUP INC | REPL | 4,866,499 | $41.0M | 12.09% |
| 6 | ENGENE HOLDINGS INC | ENGNW | 2,894,199 | $26.7M | 7.87% |
| 7 | ACHILLES THERAPEUTICS PLC | 00449L102 | 2,390,050 | $2.1M | 0.63% |
| 8 | ENGENE HOLDINGS INC | ENGNW | 3,403,072 | $2.0M | 0.60% |
| 9 | ENGENE HOLDINGS INC | ENGNW | 475,076 | $403,815 | 0.12% |